MB MAINLINE BIOSCIENCES Trademark

Trademark Overview


On Friday, November 18, 2022, a trademark application was filed for MB MAINLINE BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the MB MAINLINE BIOSCIENCES trademark a serial number of 97683391. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 7, 2025. This trademark is owned by Mainline Biosciences (Shanghai) Co., Ltd.. The MB MAINLINE BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals
mb mainline biosciences

General Information


Serial Number97683391
Word MarkMB MAINLINE BIOSCIENCES
Filing DateFriday, November 18, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, January 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements


Description of MarkThe mark consists of a stylized blue "M" to the left of a stylized light blue "B" above the stylized blue wording "MAINLINE BIOSCIENCE" above stylized blue Asian characters
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2018
NOT AVAILABLEThe non-Latin characters in the mark transliterate to "ZHULIU YUAN SHENGWUKEJI" and this means "MAIN SOURCE BIOTECHNOLOGY" in English.
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/01/2018
Goods and ServicesPharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/01/2018
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2018
Indication of Colors claimedThe color(s) blue and light blue is/are claimed as a feature of the mark.
NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesPharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMainline Biosciences (Shanghai) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLingang, Shanghai 201413
CN

Party NameMainline Biosciences (Shanghai) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLingang, Shanghai 201413
CN

Trademark Events


Event DateEvent Description
Tuesday, November 22, 2022NEW APPLICATION ENTERED
Friday, December 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 10, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Friday, September 1, 2023NON-FINAL ACTION WRITTEN
Friday, September 1, 2023NON-FINAL ACTION E-MAILED
Friday, September 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 11, 2024NON-FINAL ACTION E-MAILED
Thursday, January 11, 2024NON-FINAL ACTION WRITTEN
Thursday, January 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 11, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, April 11, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, July 17, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 17, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, July 17, 2024PETITION TO REVIVE-GRANTED
Thursday, October 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2024ASSIGNED TO LIE
Tuesday, October 29, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 29, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, October 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 29, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 7, 2025TEAS STATEMENT OF USE RECEIVED